rs267608657
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001323289.2(CDKL5):c.2376+5G>A variant causes a splice region, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001323289.2 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | c.2376+5G>A | splice_region_variant, intron_variant | Intron 16 of 17 | ENST00000623535.2 | NP_001310218.1 | ||
| CDKL5 | NM_001037343.2 | c.2376+5G>A | splice_region_variant, intron_variant | Intron 17 of 21 | NP_001032420.1 | |||
| CDKL5 | NM_003159.3 | c.2376+5G>A | splice_region_variant, intron_variant | Intron 16 of 20 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 19
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
CDKL5 disorder Pathogenic:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely pathogenic. At least the following criteria are met: This variant has been identified as a de novo occurrence in an individual with CDKL5 disorder without confirmation of paternity and maternity (PM6). The computational splicing predictor SpliceAI supports a splicing alteration (score of >0.2 - AL: 89, DL: .96) (PP3_Splicing). At least one individual with this variant has been reported with a clinical phenotype consistent with CDKL5- related condition (PP4).PMID: 19241098 This variant is absent from gnomAD v4 (PM2_Supporting). -
Atypical Rett syndrome Pathogenic:1
Predicted to abolish existing splice site, not tested in RNA -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at